| ?????? ?? ??? |
???????? |
| ????????? |
; 6,9-?????? -5 ??-??????? (1 ', 2': 1,2) ???????? (4,5-??) ????? -6-?????????????; ?? 606109; Voacanga afracina ?? ?????????? ?????; ?????? 82591; ????????; ???????????; ????????; 12-???????? -13- ((3 ?????) -17-???????? -17-??????????? -3-?????) ????????? -18-????????????? ???? ?????? ?????; ????????? -18-????????????? ????, 12-???????? -13- ((3 ?????) -17-???????? -17-??????????? -3-?????) -, ?????? ????? (9 ????); ?????? 12-????????-13- (17-????????-17-???????????-3alpha-yl) ?????????-18-?????????????; ????????? (8CI); ?????? 12-???????? -13 - [(3alpha, 19Z) -17-???????? -17-??????????? -3-?????] ????????? -18-?????????????; ?????? (2alpha) -12-???????? -13 - [(3alpha, 5alpha, 19E) -17-???????? -17-??????????? -3-?????] ????????? -18-????????????? |
| ???????? ??? |
Voacamine; 6,9-Methano-5H-pyrido(1',2':1,2)azepino(4,5-b)indole-6-carboxylic; B 606109; Crystalline compound from Voacanga afracina; NSC 82591; VOACAMINE; Voacanginine; Vocamine; 12-Methoxy-13-((3alpha)-17-methoxy-17-oxovobasan-3-yl)ibogamine-18-carboxylic acid methyl ester; Ibogamine-18-carboxylic acid, 12-methoxy-13-((3alpha)-17-methoxy-17-oxovobasan-3-yl)-, methyl ester (9CI); Methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate; Voacamine (8CI); methyl 12-methoxy-13-[(3alpha,19Z)-17-methoxy-17-oxovobasan-3-yl]ibogamine-18-carboxylate; methyl (2alpha)-12-methoxy-13-[(3alpha,5alpha,19E)-17-methoxy-17-oxovobasan-3-yl]ibogamine-18-carboxylate |
| ????? ???????? |
C43H52N4O5 |
| ?????? ??? |
704.8968 |
| InChI |
InChI=1/C43H52N4O5/c1-7-24-15-23-20-43(42(49)52-6)39-27(13-14-47(21-23)40(24)43)29-19-36(50-4)30(17-34(29)45-39)31-16-28-25(8-2)22-46(3)35(37(28)41(48)51-5)18-32-26-11-9-10-12-33(26)44-38(31)32/h8-12,17,19,23-24,28,31,35,37,40,44-45H,7,13-16,18,20-22H2,1-6H3/b25-8-/t23-,24-,28-,31+,35+,37?,40-,43+/m0/s1 |
| ??? ??????? ?????? |
3371-85-5 |
| EINECS |
222-151-3 |
| ????? ?????? |
|
| ????? |
1.309g/cm3 |
| ??????? ??????? |
1.674 |
|